Torno Capital, LLC Vertex Pharmaceuticals Inc Put Options Transaction History

Torno Capital, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	SELL	$460.0 - $505.78 $3.77 Million - $4.15 Million	-8,200 Reduced 32.8%	16,800 $7.81 Billion
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $10.8 Million - $13.4 Million	-27,500 Reduced 52.38%	25,000 $11.7 Billion
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $12.6 Million - $13.7 Million	30,800 Added 141.94%	52,500 $21.9 Billion
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $7.44 Million - $8.91 Million	21,700 New	21,700 $8.83 Billion

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Torno Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Torno Capital, LLC with notifications on news.